Company intelligence / Profile preview

Summit Doppler Systems

Ownership: Private
Development stage: Other

Overview

Summit Doppler Systems developed and commercialized a range of FDA-cleared non-invasive vascular and fetal monitoring devices. Their products are widely used for the diagnosis of peripheral arterial disease via Ankle Brachial Index exams, as well as for obstetric fetal heart rate detection. The technology is clinically validated and has been adopted in primary care, vascular labs, and obstetric settings globally.

Therapeutic areas: Women's HealthCardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Cleveland Clinic

Beyond the preview

Go deeper on Summit Doppler Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Summit Doppler Systems.

Explore the full profile